Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease
- PMID: 10072051
- DOI: 10.1002/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x
Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease
Abstract
The distribution and density of neurofibrillary tangles and amyloid plaques was studied in a unique series of cases whose premortem cognitive status had been assessed with the Clinical Dementia Rating (CDR), including 39 nondemented cases (CDR = 0; age, 51-88 years), 15 very mildly demented cases (CDR = 0.5), and 8 severely demented (CDR = 3) cases. The initial formation of tangles and plaques in healthy aging appeared to be independent of each other. Tangles were found in all the nondemented cases, especially in hippocampal and parahippocampal areas; the average tangle concentration increased exponentially with age. In contrast, plaques were absent in some brains up to age 88, and the earliest plaque formation in other cases occurred in the neocortex, in patches of diffuse plaques. Widely distributed neuritic as well as diffuse plaques throughout neocortex and limbic structures characterized a further group of nondemented cases. In these cases there was also a substantial increase over other nondemented cases, both in the number of tangles and in the rate of increase in tangles with age, suggesting an interaction between amyloid and neurofibrillary change at this stage. Such cases closely resemble CDR = 0.5 cases, and it is proposed they represent "preclinical" Alzheimer's disease.
Similar articles
-
The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease.Neurobiol Aging. 1991 Jul-Aug;12(4):295-312. doi: 10.1016/0197-4580(91)90006-6. Neurobiol Aging. 1991. PMID: 1961359
-
Diagnostic criteria for Alzheimer's disease.Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S67-70. doi: 10.1016/s0197-4580(97)00072-9. Neurobiol Aging. 1997. PMID: 9330988
-
Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia.Brain. 2012 May;135(Pt 5):1554-65. doi: 10.1093/brain/aws076. Epub 2012 Apr 19. Brain. 2012. PMID: 22522938 Free PMC article.
-
Alzheimer-type of pathological changes in Chinese.J Neurol Sci. 1997 Jan;145(1):97-103. doi: 10.1016/s0022-510x(96)00253-5. J Neurol Sci. 1997. PMID: 9073036 Review.
-
The neuropathological changes associated with normal brain aging.Histol Histopathol. 1996 Oct;11(4):1075-88. Histol Histopathol. 1996. PMID: 8930649 Review.
Cited by
-
Higher amyloid is associated with greater loneliness among cognitively normal older adults during the COVID-19 pandemic.F1000Res. 2024 Jan 24;11:1134. doi: 10.12688/f1000research.124891.2. eCollection 2022. F1000Res. 2024. PMID: 39434871 Free PMC article.
-
Face-Name Associative Memory Performance Among Cognitively Healthy Individuals, Individuals With Subjective Memory Complaints, and Patients With a Diagnosis of aMCI.Front Psychol. 2020 Sep 9;11:2173. doi: 10.3389/fpsyg.2020.02173. eCollection 2020. Front Psychol. 2020. PMID: 33041886 Free PMC article. No abstract available.
-
Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.Adv Pharmacol. 2012;64:27-81. doi: 10.1016/B978-0-12-394816-8.00002-7. Adv Pharmacol. 2012. PMID: 22840744 Free PMC article. Review.
-
Beta amyloid deposition and cognitive decline in Parkinson's disease: a study of the PPMI cohort.Mol Brain. 2022 Sep 13;15(1):79. doi: 10.1186/s13041-022-00964-1. Mol Brain. 2022. PMID: 36100909 Free PMC article.
-
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.Ann Neurol. 2012 Jun;71(6):765-75. doi: 10.1002/ana.22628. Epub 2012 Apr 9. Ann Neurol. 2012. PMID: 22488240 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical